Michael Pfeilstöcker

Author

Also Known As

A. Walder, M Pfeilstöcker, M. Pfeilstocker, M. Pfeilstöcker, M. Pfeilstöcker, Michael Pfeilstocker, Michael Pfeilstöcker, Michael Pfeilstöcker

183

Publications

8.7K

Citations

H-Index

Concepts

All Affiliations

Hanusch Hospital Medical University of Vienna Krankenhaus der Elisabethinen Innsbruck Medical University Heinrich Heine University Düsseldorf

About

Michael Pfeilstöcker is an author at Hanusch Hospital specializing in medicine, hematology, and pathology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	15	20	1.3K
2	Health Sciences	5	5	385
3	Public Health	4	4	138
4	Biostatistics	3	3	237
5	Cell Biology	2	2	37

Michael Pfeilstöcker

Publications

7.2K

Citations

H-Index

Page 1

	Year	Citations
Revised International Prognostic Scoring System for Myelodysplastic Syndromes Peter L. Greenberg, Heinz Tuechler, Julie Schanz, Blood	2012	3.1K
New insights into the prognostic impact of the karyotype in MDS and correlation with subtypes: evidence from a core dataset of 2124 patients Detlef Haase, Ulrich Germing, Julie Schanz, Blood	2007	783
New Comprehensive Cytogenetic Scoring System for Primary Myelodysplastic Syndromes (MDS) and Oligoblastic Acute Myeloid Leukemia After MDS Derived From an International Database Merge Julie Schanz, Heinz Tüchler, Françesc Solé, Journal of Clinical Oncology	2012	683
Proposed minimal diagnostic criteria for myelodysplastic syndromes (MDS) and potential pre-MDS conditions Peter Valent, Attilio Orazi, David P. Steensma, Oncotarget	2017	186
Time-dependent changes in mortality and transformation risk in MDS Michael Pfeilstöcker, Heinz Tuechler, Guillermo Sanz, Blood	2016	175
Hereditary α tryptasemia is a valid genetic biomarker for severe mediator-related symptoms in mastocytosis Georg Greiner, Bettina Sprinzl, Aleksandra Górska, Blood	2020	169
Refinement of the international prognostic scoring system (IPSS) by including LDH as an additional prognostic variable to improve risk assessment in patients with primary myelodysplastic syndromes (MDS) Ulrich Germing, Barbara Hildebrandt, Michael Pfeilstöcker, Leukemia Risk AssessmentPrognostic AssessmentPrognostic BiomarkersPrimary Myelodysplastic SyndromesAdditional Prognostic Variable	2005	161
Coalesced Multicentric Analysis of 2,351 Patients With Myelodysplastic Syndromes Indicates an Underestimation of Poor-Risk Cytogenetics of Myelodysplastic Syndromes in the International Prognostic Scoring System Julie Schanz, Christian Steidl, Christa Fonatsch, Journal of Clinical Oncology	2011	157
Validation of WHO classification-based Prognostic Scoring System (WPSS) for myelodysplastic syndromes and comparison with the revised International Prognostic Scoring System (IPSS-R). A study of the International Working Group for Prognosis in Myelodysplasia (IWG-PM) Matteo Giovanni Della Porta, Heinz Tuechler, Luca Malcovati, Leukemia Hematological MalignancyPrognosisHematologyDiagnosisPathology	2015	135
Survival, prognostic factors and rates of leukemic transformation in 381 untreated patients with MDS and del(5q): A multicenter study Ulrich Germing, Michael Lauseker, Barbara Hildebrandt, Leukemia Hematological MalignancyOncologyLeukemic TransformationUntreated PatientsCancer Treatment	2012	124

Page 1